World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
78
Citations
25876
World Ranking
1734
National Ranking
119

Andreas Mackensen publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Andreas Mackensen sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 416 publications — 83rd percentile

83% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Andreas Mackensen D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Andreas Mackensen sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 78 D-Index — 65th percentile

65% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Andreas Mackensen is affiliated with the University of Erlangen-Nuremberg in Germany and specializes in medicine with a strong focus on immunology and microbiology. Their research primarily addresses immunology, oncology, molecular biology, genetics, and hematology. The work notably revolves around CAR-T cell therapy research, immune cell function and interaction, and T-cell and B-cell immunology, alongside studies in viral infectious diseases and gene expression in insects, biosimilars and bioanalytical methods, cancer immunotherapy and biomarkers, and hematopoietic stem cell transplantation.

The scientist has contributed to a variety of publications across multiple esteemed venues. Their frequent publication outlets include Blood, Annals of the Rheumatic Diseases, Cancers, Journal for ImmunoTherapy of Cancer, and The Lancet.

Recent notable papers authored or co-authored by Andreas Mackensen are:

  • Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus (2022, Nature Medicine)
  • CD19 CAR T-Cell Therapy in Autoimmune Disease - A Case Series with Follow-up (2024, New England Journal of Medicine)
  • CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus (2021, New England Journal of Medicine)
  • CAR-HEMATOTOX: a model for CAR T-cell-related hematologic toxicity in relapsed/refractory large B-cell lymphoma (2021, Blood)
  • CAR T-cell therapy in autoimmune diseases (2023, The Lancet)

Their collaborative network includes frequent co-authors such as Simon Völkl, Fabian Müller, Michael Aigner, Dimitrios Mougiakakos, and Georg Schett.

Andreas Mackensen's research domains intersect immunological cell therapies and hematology with a particular interest in CAR-T cell therapy applications in both oncology and autoimmune diseases. Their work contributes to understanding the mechanisms behind immune cell function and interaction as well as providing insights into the clinical implications of CAR-T therapies.

Best Publications

  • Inhibitory effect of tumor cell–derived lactic acid on human T cells

    Karin Fischer;Petra Hoffmann;Simon Voelkl;Norbert Meidenbauer

  • LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells.

    Almut Brand;Katrin Singer;Gudrun E. Koehl;Marlene Kolitzus

  • Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapy.

    Christian Blank;Thomas F. Gajewski;Andreas Mackensen

  • CD19 CAR T-Cell Therapy in Autoimmune Disease — A Case Series with Follow-up

    Unknown

  • Tumor-derived lactic acid modulates dendritic cell activation and antigen expression

    Eva Gottfried;Leoni A. Kunz-Schughart;Leoni A. Kunz-Schughart;Stephanie Ebner;Stephanie Ebner;Wolfgang Mueller-Klieser;Wolfgang Mueller-Klieser

  • Contribution of the PD-L1/PD-1 pathway to T-cell exhaustion: an update on implications for chronic infections and tumor evasion.

    Christian Blank;Andreas Mackensen

  • CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus

    Dimitrios Mougiakakos;Gerhard Krönke;Simon Völkl;Sascha Kretschmann

  • Phase I study in melanoma patients of a vaccine with peptide-pulsed dendritic cells generated in vitro from CD34(+) hematopoietic progenitor cells.

    Andreas Mackensen;Birgit Herbst;Ji-Li Chen;Gabriele Köhler

  • Effector Function of Human Tumor-Specific CD8 T Cells in Melanoma Lesions: A State of Local Functional Tolerance

    Alfred Zippelius;Pascal Batard;Verena Rubio-Godoy;Gilles Bioley

  • Bispecific T-Cell Engager (BiTE) Antibody Construct Blinatumomab for the Treatment of Patients With Relapsed/Refractory Non-Hodgkin Lymphoma: Final Results From a Phase I Study

    Maria-Elisabeth Goebeler;Stefan Knop;Andreas Viardot;Peter Kufer

  • Blockade of PD-L1 (B7-H1) augments human tumor-specific T cell responses in vitro.

    Christian Blank;Juergen Kuball;Simon Voelkl;Heinz Wiendl

  • Phase I Study of Adoptive T-Cell Therapy Using Antigen-Specific CD8+ T Cells for the Treatment of Patients With Metastatic Melanoma

    Andreas Mackensen;Norbert Meidenbauer;Sandra Vogl;Monika Laumer

  • Ex vivo induction and expansion of antigen-specific cytotoxic T cells by HLA-Ig–coated artificial antigen-presenting cells

    Mathias Oelke;Marcela V. Maus;Dominic Didiano;Carl H. June

  • CAR-HEMATOTOX: A model for CAR T-cell related hematological toxicity in relapsed/refractory large B-cell lymphoma.

    Kai Rejeski;Ariel Perez Perez;Pierre Sesques;Eva Hoster

  • Isolation and characterization of human antigen-specific TCRαβ+ CD4-CD8- double-negative regulatory T cells

    Karin Fischer;Simon Voelkl;Jana Heymann;Grzegorz K. Przybylski

  • Presence of IgE antibodies to bovine serum albumin in a patient developing anaphylaxis after vaccination with human peptide-pulsed dendritic cells.

    Andreas Mackensen;Ruth Dräger;Michael Schlesier;Roland Mertelsmann

  • Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells.

    Nimitha R Mathew;Nimitha R Mathew;Francis Baumgartner;Lukas Braun;David O'Sullivan

  • CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs.

    Regina Jitschin;Martina Braun;Maike Büttner;Katja Dettmer-Wilde

  • Pembrolizumab plus lenalidomide and dexamethasone for patients with treatment-naive multiple myeloma (KEYNOTE-185): a randomised, open-label, phase 3 trial

    Saad Zafar Usmani;Fredrik Schjesvold;Albert Oriol;Lionel Karlin

  • Antigen recognition induces phosphatidylserine exposure on the cell surface of human CD8+ T cells

    Karin Fischer;Simon Voelkl;Jana Berger;Reinhard Andreesen

  • Direct evidence to support the immunosurveillance concept in a human regressive melanoma.

    A Mackensen;G Carcelain;S Viel;M C Raynal

  • Mitochondrial metabolism contributes to oxidative stress and reveals therapeutic targets in chronic lymphocytic leukemia.

    Regina Jitschin;Andreas D Hofmann;Heiko Bruns;Andreas Giessl

Frequent Co-Authors

Reinhard Andreesen
Reinhard Andreesen University of Regensburg
Marina Kreutz
Marina Kreutz University of Regensburg
Gabriele Köhler
Gabriele Köhler University of Münster
Axel Hauschild
Axel Hauschild Kiel University
Dirk Schadendorf
Dirk Schadendorf University of Duisburg-Essen
Stefan W. Krause
Stefan W. Krause University of Erlangen-Nuremberg
Michael Rehli
Michael Rehli University of Regensburg
Richard D. Pancost
Richard D. Pancost University of Bristol
Gerold Schuler
Gerold Schuler University of Erlangen-Nuremberg
Gavin L. Foster
Gavin L. Foster University of Southampton

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in expanding their expertise beyond immunology, pursuing related online degrees in nursing can open valuable career opportunities. Programs such as the cheapest pmhnp certificate programs offer affordable routes to specialize in psychiatric nursing, a field that intersects with immunological health through neuroimmune disorders.

Nurses aiming for advanced clinical roles often consider bridging pathways, like the fnp to acnp bridge program online, which allows family nurse practitioners to gain acute care expertise. These accelerated programs can quickly equip practitioners with the skills needed for critical care environments.

Understanding the financial rewards of such advanced credentials is important. Resources detailing the doctorate in nursing salary by state provide insight into expected compensation, helping students make informed decisions about their education investments.

For those ready to fast-track their nursing careers, the accelerated np programs offer streamlined paths to becoming nurse practitioners. These programs combine rigorous training with flexible online formats, suited for professionals balancing work and study.

Best Scientists Citing Andreas Mackensen

Trending Scientists